GLS and Patent ductus arteriosus: Given that glutamine is a precursor for glutathione synthesis47, and that CR-31 treatment perturbs glutathione metabolism (Fig. 3), we initially asked whether glutaminase inhibition sensitized PDA cells to CR-31 through further induction of oxidative stress.